Mo Baikoghli

MedicineBiochemistry, Genetics and Molecular BiologyMaterials Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Development of HEVNP as a Multifunctional Strategy to Combat SARS‐CoV2 as Preventive Vaccine and Antiviral Drug”.

Development of HEVNP as a Multifunctional Strategy to Combat SARS‐CoV2 as Preventive Vaccine and Antiviral Drug

ACTA SCIENTIFIC MICROBIOLOGY(2020)10.31080/asmi.2020.03.0741

N/A

0DataRank · unranked

1 citations

Mo Baikoghli, R. Holland Cheng, Chun Chieh Chen

In situ T-cell transfection by anti-CD3-conjugated lipid nanoparticles leads to T-cell activation, migration, and phenotypic shift

Biomaterials(2021)10.1016/j.biomaterials.2021.121339

N/A

0DataRank · unranked

150 citations

Aris J. Kare, Elizabeth S. Ingham, Ramasamy Paulmurugan, Elise Robinson, Mo Baikoghli +12 more

Development of 68Ga-Labeled Hepatitis E Virus Nanoparticles for Targeted Drug Delivery and Diagnostics with PET

Molecular Pharmaceutics(2022)10.1021/acs.molpharmaceut.2c00359

N/A

0DataRank · unranked

7 citations

Chun‐Chieh Chen, Mo Baikoghli, Surachet Imlimthan, You Cheng Khng, Mirkka Sarparanta +3 more